TW202333708A - 用於遞送治療劑之化合物及組合物 - Google Patents

用於遞送治療劑之化合物及組合物 Download PDF

Info

Publication number
TW202333708A
TW202333708A TW111147301A TW111147301A TW202333708A TW 202333708 A TW202333708 A TW 202333708A TW 111147301 A TW111147301 A TW 111147301A TW 111147301 A TW111147301 A TW 111147301A TW 202333708 A TW202333708 A TW 202333708A
Authority
TW
Taiwan
Prior art keywords
group
alkyl
lnp
alkenyl
lipid
Prior art date
Application number
TW111147301A
Other languages
English (en)
Chinese (zh)
Inventor
埈榮 李
摩西卓拉 西伯沙德
凱莉 E 班納圖
Original Assignee
美商現代公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商現代公司 filed Critical 美商現代公司
Publication of TW202333708A publication Critical patent/TW202333708A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW111147301A 2021-12-10 2022-12-09 用於遞送治療劑之化合物及組合物 TW202333708A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163288317P 2021-12-10 2021-12-10
US63/288,317 2021-12-10

Publications (1)

Publication Number Publication Date
TW202333708A true TW202333708A (zh) 2023-09-01

Family

ID=85076438

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111147301A TW202333708A (zh) 2021-12-10 2022-12-09 用於遞送治療劑之化合物及組合物

Country Status (7)

Country Link
US (1) US20250144036A1 (https=)
EP (1) EP4444692A1 (https=)
JP (1) JP2025502627A (https=)
CN (1) CN118369308A (https=)
AR (1) AR127892A1 (https=)
TW (1) TW202333708A (https=)
WO (1) WO2023107669A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4286012A3 (en) 2015-09-17 2024-05-29 ModernaTX, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
HUE057877T2 (hu) 2015-12-22 2022-06-28 Modernatx Inc Vegyületek és készítmények terápiás szerek intracelluláris bejuttatására
WO2018170322A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Crystal forms of amino lipids
SMT202300097T1 (it) 2017-03-15 2023-05-12 Modernatx Inc Composto e composizioni per il rilascio intracellulare di agenti terapeutici
AU2020350759A1 (en) 2019-09-19 2022-03-31 Modernatx, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
CN116969850A (zh) * 2022-06-14 2023-10-31 苏州科锐迈德生物医药科技有限公司 碳酸酯-羧酸酯型脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂
WO2024067639A1 (zh) * 2022-09-30 2024-04-04 荣灿生物医药技术(上海)有限公司 一种转染效率高的可电离脂质化合物及其应用
CN116947669B (zh) * 2022-09-30 2024-04-12 荣灿生物医药技术(上海)有限公司 一种转染效率高的可电离脂质化合物及其应用
EP4727914A1 (en) * 2023-06-14 2026-04-22 ModernaTX, Inc. Compounds and compositions for delivery of therapeutic agents
CN121463960A (zh) * 2023-06-28 2026-02-03 上海瑞宏迪医药有限公司 一种含有阳离子脂质的药物组合物及其用途
CN121889371A (zh) * 2023-07-03 2026-04-17 科纳勒生物公司 脂质及其组合物
CN116891423B (zh) * 2023-07-07 2024-03-01 荣灿生物医药技术(上海)有限公司 脂质化合物、组合物及其制备方法和应用
CN121532376A (zh) * 2023-07-19 2026-02-13 正基基因科技有限公司 脂质和脂质纳米颗粒
CN119330848B (zh) * 2023-10-19 2025-07-08 仁景(苏州)生物科技有限公司 用于递送的脂质化合物及脂质纳米颗粒
KR20250064439A (ko) * 2023-11-02 2025-05-09 주식회사 삼양홀딩스 양이온성 지질 및 이의 제조방법
CN117658839A (zh) * 2023-11-22 2024-03-08 武汉大学 一种含羟基可电离脂质及其制备方法与应用
WO2025124541A1 (zh) * 2023-12-13 2025-06-19 上海瑞宏迪医药有限公司 一种阳离子脂质及其应用
CN119798203A (zh) * 2024-01-05 2025-04-11 仁景(苏州)生物科技有限公司 用于递送的脂质化合物和脂质纳米颗粒
CN119874554B (zh) * 2024-02-02 2025-08-19 仁景(苏州)生物科技有限公司 用于递送的脂质化合物和脂质纳米颗粒
CN117695410B (zh) * 2024-02-06 2024-05-03 中国人民解放军军事科学院军事医学研究院 CRISPR/Cas9纳米抗菌剂及其制备方法
CN119264001A (zh) * 2024-04-03 2025-01-07 上海蓝鹊生物医药有限公司 含氮链状化合物、制备方法、包含其的组合物和应用
CN118388360B (zh) * 2024-04-17 2025-04-04 北京悦康科创医药科技股份有限公司 含有苯环结构的长效脾靶向阳离子脂质化合物、包含其的组合物及用途
CN118852328A (zh) * 2024-07-02 2024-10-29 北京大学 肽基可离子化脂质合成及其应用
CN119019272A (zh) * 2024-08-14 2024-11-26 中国药科大学 可电离脂质、包含其的组合物及其用途
CN119039164B (zh) * 2024-08-29 2025-04-11 国药中生生物技术研究院有限公司 可离子化脂质化合物、包含其的脂质纳米颗粒、药物组合物、药物制剂及其应用
WO2026061393A1 (zh) * 2024-09-18 2026-03-26 北京剂泰生命科技有限公司 递送编码分泌型蛋白的核酸分子的脂质纳米颗粒及其用途
CN119661389A (zh) * 2024-10-15 2025-03-21 山东大学 一种基于反式-1,4-环己烷二甲醇的可电离脂质、脂质纳米颗粒及其制备方法与应用
CN121426694B (zh) * 2025-12-31 2026-04-03 中国科学技术大学苏州高等研究院 脂质化合物或其药学上可接受的盐及其制备方法、脂质纳米颗粒和应用
CN121426693B (zh) * 2025-12-31 2026-04-03 中国科学技术大学苏州高等研究院 脂质化合物或其药学上可接受的盐及其制备方法、脂质纳米颗粒和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4286012A3 (en) 2015-09-17 2024-05-29 ModernaTX, Inc. Compounds and compositions for intracellular delivery of therapeutic agents
PL3350333T3 (pl) 2015-09-17 2022-03-07 Modernatx, Inc. Polinukleotydy zawierające region stabilizujący ogon
AU2016336344A1 (en) 2015-10-05 2018-04-19 Modernatx, Inc. Methods for therapeutic administration of messenger ribonucleic acid drugs
IL307179A (en) * 2015-10-28 2023-11-01 Acuitas Therapeutics Inc Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
HUE057877T2 (hu) 2015-12-22 2022-06-28 Modernatx Inc Vegyületek és készítmények terápiás szerek intracelluláris bejuttatására
SMT202300097T1 (it) 2017-03-15 2023-05-12 Modernatx Inc Composto e composizioni per il rilascio intracellulare di agenti terapeutici
US12077501B2 (en) 2017-06-14 2024-09-03 Modernatx, Inc. Compounds and compositions for intracellular delivery of agents
WO2021055849A1 (en) 2019-09-19 2021-03-25 Modernatx, Inc. Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents
AU2020350759A1 (en) * 2019-09-19 2022-03-31 Modernatx, Inc. Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents
BR112022004936A2 (pt) 2019-09-19 2022-06-14 Modernatx Inc Compostos lipídicos contendo carbonato e composições para distribuição intracelular de agentes terapêuticos

Also Published As

Publication number Publication date
US20250144036A1 (en) 2025-05-08
CN118369308A (zh) 2024-07-19
WO2023107669A1 (en) 2023-06-15
EP4444692A1 (en) 2024-10-16
AR127892A1 (es) 2024-03-06
JP2025502627A (ja) 2025-01-28

Similar Documents

Publication Publication Date Title
TW202333708A (zh) 用於遞送治療劑之化合物及組合物
US12428425B2 (en) Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use
JP6853307B2 (ja) ヘテロアリール化合物およびそれらの使用
CN100497346C (zh) 趋化因子ccr5受体调控剂
US20230398225A1 (en) Pd-l1/sting conjugates and methods of use
US9981910B2 (en) Substituted pyrrolidines and methods of use
EP3193851B1 (en) Combination therapies for treatment of cancer
EP4393937A1 (en) Steroid compound and conjugate thereof
US10131679B2 (en) Substituted dihydropyrrolopyrazole compound
US10696707B2 (en) Polyene macrolide derivative
US20250375391A1 (en) Lipid nanoparticle compositions comprising surface lipid derivatives and relates uses
US10894798B2 (en) Substituted dihydropyrrolopyrazole derivative
US20230405008A1 (en) Treatment of hematological malignancies with inhibitors of menin
US20220162197A1 (en) Myst family histone acetyltransferase inhibitors
US20250388565A1 (en) Estrogen receptor alpha degraders and methods of use thereof
US20220249475A1 (en) Compounds and method for treating cytokine release syndrome
US20250375389A1 (en) Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
TW202425968A (zh) 吡唑基磺醯胺化合物及其在療法中之用途
HK1235793A1 (en) Polyene macrolide derivative